Defective inactivation of leukotriene B4 in patients with Sjo ̈gren-Larsson syndrome
- 29 February 2000
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 136 (2), 258-260
- https://doi.org/10.1016/s0022-3476(00)70113-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in miceEuropean Journal of Pharmacology, 1998
- Involvement of microsomal fatty aldehyde dehydrogenase in the α‐oxidation of phytanic acidFEBS Letters, 1998
- Effects of Glucocorticoids and Progesterone on Prostaglandin E2 and Leukotriene B4 Release by Human Fetal Membranes at Term GestationProstaglandins, 1997
- Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterizationBiochimica et Biophysica Acta (BBA) - General Subjects, 1997
- Leukotrienes: Biosynthesis, Metabolism, and Pathophysiologic SignificancePediatric Research, 1995
- Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.JCI Insight, 1993
- Leukotrienes and Other Products of the 5-Lipoxygenase PathwayNew England Journal of Medicine, 1990
- Metabolism of leukotriene B4 in the monkey. Identification of the principal nonvolatile metabolite in the urineProstaglandins, 1984